Jane Street’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.08M | Sell |
10,600
-13,900
| -57% | -$2.7M | ﹤0.01% | 5017 |
|
|
2025
Q4 | $4.25M | Buy |
24,500
+17,400
| +245% | +$3.17M | ﹤0.01% | 3487 |
|
|
2025
Q3 | $1.35M | Sell |
7,100
-27,800
| -80% | -$4.93M | ﹤0.01% | 5689 |
|
|
2025
Q2 | $6.27M | Sell |
34,900
-11,100
| -24% | -$1.93M | ﹤0.01% | 2714 |
|
|
2025
Q1 | $7.78M | Buy |
46,000
+42,300
| +1,143% | +$6.95M | ﹤0.01% | 2317 |
|
|
2024
Q4 | $558K | Sell |
3,700
-3,400
| -48% | -$529K | ﹤0.01% | 6561 |
|
|
2024
Q3 | $1.1M | Buy |
7,100
+800
| +13% | +$119K | ﹤0.01% | 5681 |
|
|
2024
Q2 | $862K | Sell |
6,300
-11,900
| -65% | -$1.63M | ﹤0.01% | 6049 |
|
|
2024
Q1 | $2.42M | Buy |
18,200
+8,100
| +80% | +$1.05M | ﹤0.01% | 3794 |
|
|
2023
Q4 | $1.39M | Sell |
10,100
-7,000
| -41% | -$920K | ﹤0.01% | 4952 |
|
|
2023
Q3 | $2.08M | Buy |
17,100
+12,100
| +242% | +$1.61M | ﹤0.01% | 3994 |
|
|
2023
Q2 | $703K | Sell |
5,000
-46,800
| -90% | -$6.45M | ﹤0.01% | 5782 |
|
|
2023
Q1 | $7.33M | Buy |
51,800
+38,700
| +295% | +$5.54M | ﹤0.01% | 1964 |
|
|
2022
Q4 | $2.05M | Sell |
13,100
-11,300
| -46% | -$1.62M | ﹤0.01% | 3827 |
|
|
2022
Q3 | $2.99M | Sell |
24,400
-47,400
| -66% | -$6.24M | ﹤0.01% | 3463 |
|
|
2022
Q2 | $9.55M | Sell |
71,800
-28,200
| -28% | -$3.84M | ﹤0.01% | 1805 |
|
|
2022
Q1 | $13.7M | Buy |
100,000
+61,000
| +156% | +$8.5M | ﹤0.01% | 1618 |
|
|
2021
Q4 | $6.75M | Sell |
39,000
-62,700
| -62% | -$9.54M | ﹤0.01% | 2401 |
|
|
2021
Q3 | $14.8M | Buy |
101,700
+49,000
| +93% | +$7.17M | 0.01% | 1368 |
|
|
2021
Q2 | $6.96M | Buy |
52,700
+32,900
| +166% | +$4.31M | ﹤0.01% | 2173 |
|
|
2021
Q1 | $2.54M | Sell |
19,800
-115,000
| -85% | -$14.2M | ﹤0.01% | 3568 |
|
|
2020
Q4 | $16.1M | Buy |
134,800
+38,300
| +40% | +$4.67M | 0.01% | 1024 |
|
|
2020
Q3 | $11M | Buy |
96,500
+85,800
| +802% | +$10.1M | 0.01% | 1138 |
|
|
2020
Q2 | $1.22M | Sell |
10,700
-30,600
| -74% | -$3.25M | ﹤0.01% | 3779 |
|
|
2020
Q1 | $3.32M | Buy |
41,300
+38,500
| +1,375% | +$3.99M | ﹤0.01% | 1528 |
|
|
2019
Q4 | $299K | Buy |
+2,800
| New | +$292K | ﹤0.01% | 4275 |
|
|
2019
Q2 | – | Sell |
-11,300
| Closed | -$1.02M | – | 5212 |
|
|
2019
Q1 | $1.02M | Buy |
11,300
+7,700
| +214% | +$667K | ﹤0.01% | 2782 |
|
|
2018
Q4 | $300K | Buy |
+3,600
| New | +$338K | ﹤0.01% | 4064 |
|
|
2017
Q4 | – | Sell |
-6,600
| Closed | -$618K | – | 4660 |
|
|
2017
Q3 | $618K | Buy |
+6,600
| New | +$701K | ﹤0.01% | 2838 |
|
|
2016
Q2 | – | Sell |
-4,400
| Closed | -$314K | – | 4145 |
|
|
2016
Q1 | $314K | Buy |
+4,400
| New | +$295K | ﹤0.01% | 3144 |
|
Other funds holding DGX
VCM
VPM
EIG
Jane Street's DGX Position: Q1 2026 in Review
Jane Street reduced its Quest Diagnostics (DGX) stake by 98% in Q1 2026, selling an estimated $55.6M and leaving 6,429 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #6017.
Jane Street first reported a position in DGX in Q3 2013 and has held it in 39 quarters since. The position peaked at $50.8M in Q4 2025. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Jane Street held 6,429 shares of Quest Diagnostics worth $1.26M as of Q1 2026.
- Jane Street sold 286,305 Quest Diagnostics shares in Q1 2026, an estimated $55.6M.
- Quest Diagnostics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6017 holding.
- Jane Street first reported a position in Quest Diagnostics in Q3 2013 and has held it in 39 quarters since.
- Jane Street's Quest Diagnostics position peaked at $50.8M in Q4 2025.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.